The STOP-HPV Trial 2: Performance Feedback Intervention

Completed · Not applicable

Conditions studied: Immunization, Vaccination

In brief

Most adolescents who receive human papillomavirus (HPV) vaccine are vaccinated in pediatric practices, yet missed opportunities (MOs) for HPV vaccination occur often and lead to low HPV vaccination rates. This cluster randomized clinical trial (RCT) will test the effectiveness (and cost-effectiveness) of the addition of performance feedback (period 2) to training providers previously received on HPV vaccine communication (period 1) to reduce MOs and increase HPV vaccination rates.

Key facts

Study ID
NCT03599570
Run by
University of California, Los Angeles
People needed
48
Starts
2018-08-07
Expected to finish
2020-03-06
Last updated by the study team
2020-04-30

Who can join

Age: 11 and older, up to 17. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.